Gianluca Caiazzo

ORCID: 0000-0002-1215-8273
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Peripheral Artery Disease Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • COVID-19 and healthcare impacts
  • Aortic aneurysm repair treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Arrest and Resuscitation
  • Lipoproteins and Cardiovascular Health
  • Vascular Procedures and Complications
  • Venous Thromboembolism Diagnosis and Management
  • Blood Pressure and Hypertension Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 Clinical Research Studies
  • Cardiovascular Health and Disease Prevention
  • Cardiac and Coronary Surgery Techniques
  • Photoacoustic and Ultrasonic Imaging
  • Cardiac electrophysiology and arrhythmias
  • Advanced MRI Techniques and Applications
  • Cardiovascular Issues in Pregnancy
  • Central Venous Catheters and Hemodialysis
  • Mechanical Circulatory Support Devices
  • Epilepsy research and treatment

Azienda Ospedaliera S.Giuseppe Moscati
2015-2025

Ospedale San Giuseppe
2020-2023

Presidio Ospedaliero
2020-2022

Hospital Universitario de Canarias
2021

University Medical Center Utrecht
2021

Ospedale Santa Chiara
2021

Ospedale Santa Maria
2021

Università Campus Bio-Medico
2020

Institute of Cardiology
2020

Jagiellonian University
2020

10.1016/j.jacc.2020.09.546 article EN publisher-specific-oa Journal of the American College of Cardiology 2020-11-01

Background . Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets a major source for circulating microRNAs. Interestingly, the levels of specific were reported correlate with level platelet activation. The aim present study was test whether treatment novel antiplatelet agent, ticagrelor, is associated modulation in key platelet-derived Methods and Results Patients randomly selected from those participating SHIFT-OVER study,...

10.1155/2016/3968206 article EN BioMed Research International 2016-01-01

Aims The purpose of the EASTBOURNE registry is to evaluate immediate and long-term clinical performance a novel sirolimus-coated balloon (SCB) in real-world population patients with coronary artery disease. We here present prespecified interim analysis after enrollment first 642 who obtained 1-year follow-up. Methods prospective, international, multicenter, all-comer investigator-driven registry, which enrolling consecutive treated SCB at 42 European Asiatic centers. Primary study endpoint...

10.2459/jcm.0000000000001070 article EN Journal of Cardiovascular Medicine 2020-07-28
Giuseppe De Luca Magdy Algowhary Berat Uğuz Dinaldo Cavalcanti de Oliveira V. I. Ganyukov and 88 more Zan Zimbakov Miha Čerček Lisette Okkels Jensen Poay Huan Loh Lucian Câlmâc Gerard Roura-Ferrer Alexandre Schaan de Quadros Marek Milewski Fortunato Scotto di Uccio Clemens von Birgelen Francesco Versaci Jurriën M. ten Berg Gianni Casella Aaron Sung Lung Wong Petr Kala José Luis Díez Gil Xavier Carrillo Maurits T. Dirksen Víctor Manuel Becerra‐Muñoz Michael Lee Dafsah Arifa Juzar Rodrigo de Moura Joaquim Roberto Paladino Davor Miličić Periklis Davlouros Nikola Bakraceski Filippo Zilio Luca Donazzan Adriaan O. Kraaijeveld Gennaro Galasso Árpád Lux Lucia Marinucci Vincenzo Guiducci Maurizio Menichelli Alessandra Scoccia Aylin Hatice Yamaç Kadir Uğur Mert Xacobe Flores‐Ríos Tomáš Kovárník Michał Kidawa José Moreu Flavien Vincent Enrico Fabris Íñigo Lozano Marco Boccalatte Francisco Bosa Ojeda Carlos Arellano Serrano Gianluca Caiazzo Giuseppe Cirrincione Hsien‐Li Kao Juan Sanchís Luigi Vignali Hélder Pereira Stéphane Manzo‐Silberman Santiago Ordóñez Alev Arat Özkan Bruno Scheller Heidi Lehtola Rui Campante Teles Christos Mantis Ylitalo Antti João Silveira Rodrigo Zoni И. С. Бессонов Stefano Savonitto George Kochiadakis Dimitrios Alexopoulos C. Uribe John Kanakakis Benjamin Faurie Gabriele Gabrielli Alejandro Gutiérrez Juan Pablo Bachini Alex Rocha Franckie Cc Tam Alfredo E. Rodríguez Antonia Anna Lukito Veauthyelau Saint-Joy Gustavo Pessah Bernardino Tuccillo Giuliana Cortese Guido Parodi Mohamed Abed Bouraghda Elvin Kedhi Pablo Lamelas Harry Suryapranata Matteo Nardin Monica Verdoia

The initial data of the International Study on Acute Coronary Syndromes - ST Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction primary percutaneous coronary intervention procedures and higher in-hospital mortality during phase pandemic as compared with prepandemic period. aim current study was to provide final results registry, subsequently extended outside larger inclusion period (up June 2020) longer follow-up 30 days).This is retrospective multicentre...

10.1136/heartjnl-2021-319750 article EN Heart 2021-10-28

10.1016/j.atherosclerosis.2021.06.926 article EN other-oa Atherosclerosis 2021-07-21

Abstract Background It has been suggested the COVID pandemic may have indirectly affected treatment and outcome of STEMI patients, by avoidance or significant delays in contacting emergency system. No data reported on impact diabetes that was therefore aim current subanalysis conducted patients included International Study Acute Coronary Syndromes–ST Elevation Myocardial Infarction (ISACS-STEMI) COVID-19. Methods The ISACS-STEMI COVID-19 is a retrospective registry performed European centers...

10.1186/s12933-020-01196-0 article EN cc-by Cardiovascular Diabetology 2020-12-01

We aimed to compare intracoronary (IC) epinephrine versus conventional treatments alone in patients with ST-elevation myocardial infarction and refractory coronary no-reflow during primary percutaneous intervention (PPCI).Thirty consecutive severe (TIMI 0-1, MBG 0-1) PPCI were prospectively included after initial failure of treatments. Conventional used both groups IC nitrates, thrombectomy. Glycoprotein IIb/IIIa inhibitors adenosine. Patients received or no epinephrine.Intracoronary...

10.1002/ccd.29113 article EN Catheterization and Cardiovascular Interventions 2020-07-17
Monica Verdoia Magdy Algowhary Berat Uğuz Dinaldo Cavalcanti de Oliveira V. I. Ganyukov and 87 more Zan Zimbakov Miha Čerček Lisette Okkels Jensen Poay Huan Loh Lucian Câlmâc Gerard Roura Ferrer Alexandre Schaan de Quadros Marek Malewski Fortunato Scotto di Uccio Clemens von Birgelen Francesco Versaci Jurriën M. ten Berg Gianni Casella Aaron Wong Sung Lung Petr Kala José Luis Díez Gil Xavier Carillo Maurits T. Dirksen Víctor Manuel Becerra‐Muñoz Michael Lee Dafsah Arifa Juzar Rodrigo de Moura Joaquim Roberto Paladino Davor Miličić Periklis Davlouros Nikola Bakraceski Filippo Zilio Luca Donazzan Adriaan O. Kraaijeveld Gennaro Galasso Árpád Lux Lucia Marinucci Vincenzo Guiducci Maurizio Menichelli Alessandra Scoccia Aylin Hatice Yamaç Kadir Uğur Mert Xacobe Flores‐Ríos Tomáš Kovárník Michał Kidawa José Moreu Flavien Vincent Enrico Fabris Íñigo Lozano Marco Boccalatte Francisco Bosa Ojeda Carlos Arellano Serrano Gianluca Caiazzo Giuseppe Cirrincione Hsien‐Li Kao Juan Sanchís Luigi Vignali Hélder Pereira Stephane Manzo-Silbermann Santiago Ordóñez Alev Arat Özkan Bruno Scheller Heidi Lehtola Rui Campante Teles Christos Mantis Ylitalo Antti João Silveira Rodrigo Zoni И. С. Бессонов Stefano Savonitto George Kochiadakis Dimitrios Alexopulos C. Uribe John Kanakakis Benjamin Faurie Gabriele Gabrielli Alejandro Gutiérrez Jaun Pablo Bachini Alex Rocha Frankie Chor-Cheung Tam Alfredo Rodriguez Antonia Anna Lukito Veauthyelau Saint Joy Gustavo Pessah Giuliana Cortese Guido Parodi Mohammed Abed Burgadha Elvin Kedhi Pablo Lamelas Harry Suryapranata Matteo Nardin Monica Verdoia

Background: Several scores have been developed to facilitate risk stratification and early discharge following primary angioplasty, particularly the Zwolle Risk Score (ZRS). However, validation in large-sized studies is still lacking. Therefore, aim of current study was validate use ZRS a contemporary global population, including patients who were treated during SARS-CoV-2 pandemic enrolled large intercontinental observational study. Methods: The ISACS-STEMI COVID-19 large-scale...

10.2174/0115701611335913250408214530 article EN Current Vascular Pharmacology 2025-04-16

To expand the paucity of data on efficacy various drug-eluting stents in diabetic patients.Type 2 patients treated our institution from October 2005 to January 2007 presenting with de novo lesions native coronary arteries were randomly assigned sirolimus-eluting (Cypher group; n=76); paclitaxel-eluting (Taxus n=75); and everolimus-eluting (Endeavor n=75). Poor metabolic control (HbA1c >7% low-density lipoprotein cholesterol >100 mg/dL) microvascular complications (retinopathy and/or...

10.1161/circinterventions.110.959924 article EN Circulation Cardiovascular Interventions 2011-03-02

While bioresorbable vascular scaffolds (BVS) are increasingly used in clinical practice, their behaviour when post-dilated beyond recommended maximum overexpansion diameter remains sparsely documented. We aimed to test the of BVS scaffold vitro and evaluate impact excessive oversizing on focal point support.We examined post-expansion (3.0 mm 3.5 Absorb BVS; Abbott Vascular, Santa Clara, CA, USA) after with non-compliant (NC) balloons increasing diameters. After each step, were measured...

10.4244/eijy15m07_02 article EN EuroIntervention 2016-03-01

Abstract Background The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if might derive a benefit from the use drug-coated balloons. Aims To evaluate impact diabetes mellitus on undergoing PCI with sirolimus-coated balloon (SCB) MagicTouch (Concept Medical, India). Methods We conducted subgroup analysis prospective, multicenter, investigator-initiated EASTBOURNE registry, evaluating performance SCB without diabetes. study...

10.1186/s12933-024-02139-9 article EN cc-by Cardiovascular Diabetology 2024-02-03

Background— Ticagrelor outperforms clopidogrel in preventing cardiovascular events acute coronary syndrome. Despite the inclusion of a loading dose Platelet Inhibition and Patient Outcomes (PLATO) trial for all patients randomized to ticagrelor, it may not be necessary receiving ongoing therapy. The aim present study was assess whether ticagrelor is associated with further platelet inhibition during switch from syndrome antiplatelet treatment. Methods Results— Fifty aspirin treatment were...

10.1161/circinterventions.113.000512 article EN Circulation Cardiovascular Interventions 2014-01-22

Optical coherence tomography (OCT) was used to investigate integrity and expansion of bioresorbable drug-eluting scaffolds (BVS) after high-pressure postdilation (HPPD).Because concerns about the risk BVS damage, not recommended applied in existing randomized studies most registries. Recent real world data suggest incomplete cause higher rates thrombosis. In vivo confirmation safety high pressure is paramount importance.Data from final OCT examination consecutive implanted BVS, postdilated...

10.1002/ccd.26222 article EN Catheterization and Cardiovascular Interventions 2015-09-15
Coming Soon ...